The Q-POC machine, costing 500 UK pounds, can micro-analyse tumours and the genetic signatures of the disease before advising on the best type of drugs to use.
Using his garage in Uckfield, East Sussex, as a makeshift laboratory, 37-year-old Jonathan O'Halloran hit on the ground-breaking idea of releasing DNA within a barely visible sample and making multiple copies to allow an accurate diagnosis, whether cancer mutations exist and which oncology drugs will work best.
The device is undergoing rigorous clinical trials and will be used across the National Health Service (NHS) as early as next year, the 'Daily Express' reported.
The first prototypes are in advanced trials and experts say they have the potential to prolong the lives of newly-diagnosed cancer sufferers and save the lives of millions with infectious diseases.
'We are using the device to extract, amplify and analyse DNA from tumours or other samples to make sure the patient gets a personalised service as soon as possible,' said O'Halloran.
'We see this working alongside histopathologists and clinical oncologists to provide the missing link – a personalised service for cancer sufferers.
'It will also provide rapid diagnosis for TB, malaria, HIV and STIs [sexually transmitted infections], giving doctors key information on which drugs will treat the disease. The idea now is to make these devices available to doctors and health professionals,' he said.
The invention is being developed by British company QuantuMDx Group in partnership with Newcastle University." (Source)
[Pendant ce temps, la loi française interdit à l'usager de la santé de faire séquençer son génome. Cela va être rappelé aux journées de l'Agence de la biomédecine demain et après-demain à Paris. Putain, la honte...]
[L’Agence de la biomédecine a le plaisir de vous inviter aux 3ème Journées de l’Agence de la biomédecine jeudi 30 et vendredi 31 mai 2013, Université Paris Descartes, Paris (source)]